Clinical Trial Update: Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA® [Phase 1, Phase 2]

View source ↗

Summary

Open-label, randomized study assessing efficacy, safety and dose selection of VM-1500A-LAI in HIV-1-infected patients transitioning from NNRTI + 2 NRTIs therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ELPIDA®
• VM-1500A-LAI

Snippet

Sponsor: Viriom | Conditions: HIV-1-infection | Phase 1, Phase 2 | Status: COMPLETED